Value
4.5/10data confidence 40%| Component | Sub-score |
|---|---|
| P/S | 8.4 |
| EV/EBITDA | 0.7 |
BH-A · Why this verdict
Why Biglari Holdings (BH-A) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.6/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Biglari Holdings has near-perfect balance sheet health and passing price momentum, but business quality scores are below the minimum floor, the stock has about 2% upside to its price target with an unfavorable 0.29-to-1 reward-to-risk ratio, and an RSI reading of 93 signals price is significantly stretched from trend.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Business quality scores at 3.6 — below the 4.0 minimum threshold — reflecting near-zero net margins, negligible return on equity, and no recognized competitive moat, collectively indicating fragile fundamental health at current price levels. Warnings | Quality score rises above 4.5 from the current 3.6, driven by margin improvement and return metrics recovering above token levels, within 12 months. | →Stable |
| CounterA perfect balance sheet health score of 9 out of 9 signals that the structural financial position is sound; if revenue trends improve, profitability ratios could recover faster than the current quality reading implies. | ||
With an RSI of 93 — well into extreme overbought territory — and a death cross technical pattern still in place, price appears significantly stretched from trend, increasing the risk of a sharp near-term reversal even as MACD shows early improvement. Momentum breakdown | RSI normalizes below 70 without a sustained breakdown below the 200-day moving average within the next 60 days. | →Stable |
| CounterThe setup is classified as a recovery pattern with MACD improving alongside rising volume accumulation; an extremely high RSI in this context may reflect re-rating momentum rather than distribution, and could persist longer than historical norms suggest. | ||
The stock is flagged for effectively exhausted upside with only about 2% headroom to the price target and a reward-to-risk ratio of 0.29-to-1 — the risk of loss substantially outweighs the remaining potential gain at current prices. Gates warning | If this concern resolves, price rises above $2,000 from the current $1,795, demonstrating that meaningful additional upside existed above the apparent resistance ceiling. | →Stable |
| CounterPrice targets represent near-term resistance, not hard ceilings; if the recovery pattern continues and operating performance improves, resistance levels can be exceeded and new targets established without requiring a pullback. | ||
Despite thin profitability, the business scores 9 out of 9 on the Piotroski balance sheet health measure — a perfect reading that signals good liquidity, absence of the accounting red flags that often precede financial distress, and structural financial stability. Quality breakdown | Piotroski F-score remains at 8 or above over the next two fiscal years, confirming balance sheet stability persists. | →Stable |
| CounterA perfect Piotroski score measures historical balance sheet health, not future trajectory; with near-zero profitability and elevated leverage, the balance sheet could deteriorate quickly if operating cash flows weaken. | ||
Business quality scores at 3.6 — below the 4.0 minimum threshold — reflecting near-zero net margins, negligible return on equity, and no recognized competitive moat, collectively indicating fragile fundamental health at current price levels.
→StableWarnings
- Expectation
- Quality score rises above 4.5 from the current 3.6, driven by margin improvement and return metrics recovering above token levels, within 12 months.
CounterA perfect balance sheet health score of 9 out of 9 signals that the structural financial position is sound; if revenue trends improve, profitability ratios could recover faster than the current quality reading implies.
With an RSI of 93 — well into extreme overbought territory — and a death cross technical pattern still in place, price appears significantly stretched from trend, increasing the risk of a sharp near-term reversal even as MACD shows early improvement.
→StableMomentum breakdown
- Expectation
- RSI normalizes below 70 without a sustained breakdown below the 200-day moving average within the next 60 days.
CounterThe setup is classified as a recovery pattern with MACD improving alongside rising volume accumulation; an extremely high RSI in this context may reflect re-rating momentum rather than distribution, and could persist longer than historical norms suggest.
The stock is flagged for effectively exhausted upside with only about 2% headroom to the price target and a reward-to-risk ratio of 0.29-to-1 — the risk of loss substantially outweighs the remaining potential gain at current prices.
→StableGates warning
- Expectation
- If this concern resolves, price rises above $2,000 from the current $1,795, demonstrating that meaningful additional upside existed above the apparent resistance ceiling.
CounterPrice targets represent near-term resistance, not hard ceilings; if the recovery pattern continues and operating performance improves, resistance levels can be exceeded and new targets established without requiring a pullback.
Despite thin profitability, the business scores 9 out of 9 on the Piotroski balance sheet health measure — a perfect reading that signals good liquidity, absence of the accounting red flags that often precede financial distress, and structural financial stability.
→StableQuality breakdown
- Expectation
- Piotroski F-score remains at 8 or above over the next two fiscal years, confirming balance sheet stability persists.
CounterA perfect Piotroski score measures historical balance sheet health, not future trajectory; with near-zero profitability and elevated leverage, the balance sheet could deteriorate quickly if operating cash flows weaken.
Per-dimension breakdown
Quality
3.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 1.0 |
| Gross margin | 3.7 |
| Op margin | 1.2 |
| Net margin | 0.0 |
| Current ratio | 8.4 |
| Moat | 4.6 |
| Piotroski F | 10.0 |
- ▸No competitive moat
- ▸Strong Piotroski F-Score: 9/9
Growth
3.1/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 3.1 |
Momentum
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.0 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Overbought (RSI 81)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.0/10data confidence 67%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| erm sentiment | 5.0 |
Insider
7.4/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 9.0 |
| insider conviction | 8.0 |
| holder change | 5.1 |
- ▸Heavy insider buying — $14,098,396 (1.239% of mkt cap)
Peer rank
2.4/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.0 |
| quality rank | 0.0 |
| growth rank | 0.5 |
Technical
2.9/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.4 |
| support resistance | 0.4 |
| 52w position | 4.7 |
| gap | 5.0 |
Risk (lower is worse)
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.8 |
| days to cover | 10.0 |
| volatility | 0.4 |
| beta | 9.4 |
| debt equity | 6.9 |
Catalyst
6.1/10data confidence 75%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 3.3 |
| surprise avg | 10.0 |
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (6)
- MOMENTUM:6.6>=5.5
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:NO_DATE
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- INSIDER:1.24%=EXTREME
Warning (1)
- ASYMMETRY:UPSIDE_EXHAUSTED (upside=0.0%)
Reward-to-Risk
0.00
Upside
+0.0%
Downside
15.0%
Sizing output
AVOID
SetupRECOVERY — Death cross but MACD improving, RSI 81
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — MCap $1.1B<$5B
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Insider at 7.4 could not lift the engine output above the verdict floor. Failed gate signal: INSIDER:1.24%=EXTREME.
The strongest dimensions are Insider at 7.4, Momentum at 6.6, and Risk (lower is worse) at 6.5; the weakest are Peer rank at 2.4, Technical at 2.9, and Growth at 3.1. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 0.00 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1With an RSI of 93 — well into extreme overbought territory — and a death cross technical pattern still in place, price appears significantly stretched from trend, increasing the risk of a sharp near-term reversal even as MACD shows early improvement.
Trip ifPrice rises above $2,064 (approximately 15% above the current $1,795) within 90 days, demonstrating the RSI 93 reading was not predictive of a near-term reversal.
- P2The stock is flagged for effectively exhausted upside with only about 2% headroom to the price target and a reward-to-risk ratio of 0.29-to-1 — the risk of loss substantially outweighs the remaining potential gain at current prices.
Trip ifPrice rises above $2,000 from the current $1,795, demonstrating that meaningful upside existed above the stated $1,830 price target.
- P3Business quality scores at 3.6 — below the 4.0 minimum threshold — reflecting near-zero net margins, negligible return on equity, and no recognized competitive moat, collectively indicating fragile fundamental health at current price levels.
Trip ifQuality score rises above 4.5 from the current 3.6, indicating clear recovery above the 4.0 minimum floor.
- P4Despite thin profitability, the business scores 9 out of 9 on the Piotroski balance sheet health measure — a perfect reading that signals good liquidity, absence of the accounting red flags that often precede financial distress, and structural financial stability.
Trip ifPiotroski F-score drops below 6 for 2 consecutive fiscal years, indicating a meaningful deterioration in balance sheet health from the current perfect score.